| Leucine-rich repeats and pathogen recognition in Toll-like receptors JK Bell, GED Mullen, CA Leifer, A Mazzoni, DR Davies, DM Segal Trends in immunology 24 (10), 528-533, 2003 | 1081 | 2003 |
| Copper bis (thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships JL Dearling, JS Lewis, GE Mullen, MJ Welch, PJ Blower JBIC Journal of Biological Inorganic Chemistry 7 (3), 249-259, 2002 | 355 | 2002 |
| Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria EM Malkin, DJ Diemert, JH McArthur, JR Perreault, AP Miles, BK Giersing, ... Infection and immunity 73 (6), 3677-3685, 2005 | 330 | 2005 |
| A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali I Sagara, A Dicko, RD Ellis, MP Fay, SI Diawara, MH Assadou, ... Vaccine 27 (23), 3090-3098, 2009 | 257 | 2009 |
| Studies on the mechanism of hypoxic selectivity in copper bis (thiosemicarbazone) radiopharmaceuticals RI Maurer, PJ Blower, JR Dilworth, CA Reynolds, Y Zheng, GED Mullen Journal of medicinal chemistry 45 (7), 1420-1431, 2002 | 245 | 2002 |
| Efficient bifunctional gallium-68 chelators for positron emission tomography: tris (hydroxypyridinone) ligands DJ Berry, Y Ma, JR Ballinger, R Tavaré, A Koers, K Sunassee, T Zhou, ... Chemical communications 47 (25), 7068-7070, 2011 | 191 | 2011 |
| Sialoadhesin–a macrophage‐restricted marker of immunoregulation and inflammation ASG O'Neill, TK van den Berg, GED Mullen Immunology 138 (3), 198-207, 2013 | 164 | 2013 |
| National Electrical Manufacturers Association NU-4 performance evaluation of the PET component of the NanoPET/CT preclinical PET/CT scanner I Szanda, J Mackewn, G Patay, P Major, K Sunassee, GE Mullen, ... Journal of nuclear medicine 52 (11), 1741-1747, 2011 | 161 | 2011 |
| Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria GED Mullen, RD Ellis, K Miura, E Malkin, C Nolan, M Hay, MP Fay, A Saul, ... PLoS One 3 (8), e2940, 2008 | 151 | 2008 |
| A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4 MN Kennedy, GED Mullen, CA Leifer, CW Lee, A Mazzoni, KN Dileepan, ... Journal of Biological Chemistry 279 (33), 34698-34704, 2004 | 149 | 2004 |
| Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro JLJ Dearling, JS Lewis, GED Mullen, MT Rae, J Zweit, PJ Blower European journal of nuclear medicine 25 (7), 788-792, 1998 | 145 | 1998 |
| Towards new transition metal-based hypoxic selective agents for therapy and imaging PJ Blower, JR Dilworth, RI Maurer, GD Mullen, CA Reynolds, Y Zheng Journal of inorganic biochemistry 85 (1), 15-22, 2001 | 128 | 2001 |
| [89Zr]Oxinate4 for long-term in vivo cell tracking by positron emission tomography P Charoenphun, LK Meszaros, K Chuamsaamarkkee, E Sharif-Paghaleh, ... European journal of nuclear medicine and molecular imaging 42 (2), 278-287, 2015 | 127 | 2015 |
| Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP142-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults RD Ellis, LB Martin, D Shaffer, CA Long, K Miura, MP Fay, DL Narum, ... PloS one 5 (1), e8787, 2010 | 114 | 2010 |
| 68Ga-THP-PSMA: a PET imaging agent for prostate cancer offering rapid, room-temperature, 1-step kit-based radiolabeling JD Young, V Abbate, C Imberti, LK Meszaros, MT Ma, SYA Terry, ... Journal of Nuclear Medicine 58 (8), 1270-1277, 2017 | 113 | 2017 |
| Malaria vaccines: are we getting closer? JE Epstein, B Giersing, G Mullen, V Moorthy, TL Richie Current opinion in molecular therapeutics 9 (1), 12-24, 2007 | 113 | 2007 |
| A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel®+ CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian … I Sagara, RD Ellis, A Dicko, MB Niambele, B Kamate, O Guindo, ... Vaccine 27 (52), 7292-7298, 2009 | 112 | 2009 |
| Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates F Qian, Y Wu, O Muratova, H Zhou, G Dobrescu, P Duggan, L Lynn, ... Vaccine 25 (20), 3923-3933, 2007 | 99 | 2007 |
| Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined … K Miura, H Zhou, A Diouf, SE Moretz, MP Fay, LH Miller, LB Martin, ... Clinical and Vaccine Immunology 16 (7), 963-968, 2009 | 98 | 2009 |
| The role of disulfide bonds in the assembly and function of MD-2 GED Mullen, MN Kennedy, A Visintin, A Mazzoni, CA Leifer, DR Davies, ... Proceedings of the National Academy of Sciences 100 (7), 3919-3924, 2003 | 98 | 2003 |
